Consolidated Reporting of Opioid-Use Disorder Related Expenditures - Fiscal Year 2023

This report provides actual expenditures for fiscal year 2023 by program and method of finance as required by the 2024-2025 General Appropriations Act. The report provides information regarding $116.8 million in opioid-related expenditures.